107322,1,Admission,O
107322,1,Date,O
107322,1,:,O
107322,1,[,O
107322,1,**2104-8-8**,O
107322,1,],O
107322,1,Discharge,O
107322,1,Date,O
107322,1,:,O
107322,1,[,O
107322,1,**2104-8-27**,O
107322,1,],O
107322,1,Date,O
107322,1,of,O
107322,1,Birth,O
107322,1,:,O
107322,1,[,O
107322,1,**2027-2-15**,O
107322,1,],O
107322,1,Sex,O
107322,1,:,O
107322,1,M,O
107322,1,Service,O
107322,1,:,O
107322,1,MEDICINE,O
107322,1,Allergies,O
107322,1,:,O
107322,1,Lisinopril,B-Drug
107322,1,Attending,O
107322,1,:,O
107322,1,[,O
107322,1,**Last,O
107322,1,Name,O
107322,1,(,O
107322,1,NamePattern4,O
107322,1,),O
107322,1,290**,O
107322,1,],O
107322,1,Chief,O
107322,1,Complaint,O
107322,1,:,O
107322,1,hypoxia,O
107322,1,and,O
107322,1,confusion,O
107322,1,Major,O
107322,1,Surgical,O
107322,1,or,O
107322,1,Invasive,O
107322,1,Procedure,O
107322,1,:,O
107322,1,None,O
107322,1,History,O
107322,1,of,O
107322,1,Present,O
107322,1,Illness,O
107322,1,:,O
107322,1,77,O
107322,1,y/o,O
107322,1,M,O
107322,1,with,O
107322,1,h/o,O
107322,1,CHF,O
107322,1,(,O
107322,1,EF=,O
107322,1,40-45,O
107322,1,%,O
107322,1,on,O
107322,1,ECHO,O
107322,1,[,O
107322,1,**4-/2104**,O
107322,1,],O
107322,1,),O
107322,1,",",O
107322,1,atrial,B-Reason
107322,1,fibrillation,I-Reason
107322,1,on,O
107322,1,Coumadin,B-Drug
107322,1,presented,O
107322,1,to,O
107322,1,[,O
107322,1,**Hospital1,O
107322,1,18**,O
107322,1,],O
107322,1,as,O
107322,1,transfer,O
107322,1,from,O
107322,1,[,O
107322,1,**Hospital6,O
107322,1,5016**,O
107322,1,],O
107322,1,in,O
107322,1,[,O
107322,1,**Location,O
107322,1,(,O
107322,1,un,O
107322,1,),O
107322,1,7661**,O
107322,1,],O
107322,1,",",O
107322,1,MA,O
107322,1,for,O
107322,1,further,O
107322,1,management,O
107322,1,of,O
107322,1,hypoxia,O
107322,1,due,O
107322,1,to,O
107322,1,left,O
107322,1,upper,O
107322,1,lobe,O
107322,1,pneumonia,O
107322,1,and,O
107322,1,and,O
107322,1,ongoing,O
107322,1,delirium,O
107322,1,due,O
107322,1,to,O
107322,1,previous,O
107322,1,aspiration,O
107322,1,pneumonia,O
107322,1,(,O
107322,1,right,O
107322,1,middle,O
107322,1,lobe,O
107322,1,),O
107322,1,.,O
107322,1,The,O
107322,1,patient,O
107322,1,'s,O
107322,1,current,O
107322,1,history,O
107322,1,starts,O
107322,1,[,O
107322,1,**2104-7-15**,O
107322,1,],O
107322,1,",",O
107322,1,when,O
107322,1,he,O
107322,1,was,O
107322,1,hospitalized,O
107322,1,at,O
107322,1,[,O
107322,1,**Hospital1,O
107322,1,18**,O
107322,1,],O
107322,1,(,O
107322,1,requiring,O
107322,1,a,O
107322,1,brief,O
107322,1,ICU,O
107322,1,stay,O
107322,1,),O
107322,1,for,O
107322,1,left,B-Reason
107322,1,upper,I-Reason
107322,1,lobe,I-Reason
107322,1,pneumonia,I-Reason
107322,1,",",O
107322,1,treated,O
107322,1,with,O
107322,1,levofloxacin,B-Drug
107322,1,X7,O
107322,1,day,O
107322,1,course,O
107322,1,.,O
107322,1,He,O
107322,1,was,O
107322,1,discharged,O
107322,1,home,O
107322,1,with,O
107322,1,[,O
107322,1,**Hospital1,O
107322,1,269**,O
107322,1,],O
107322,1,",",O
107322,1,but,O
107322,1,around,O
107322,1,[,O
107322,1,**7-25**,O
107322,1,],O
107322,1,he,O
107322,1,started,O
107322,1,having,O
107322,1,hypoxia,O
107322,1,(,O
107322,1,resting,O
107322,1,O2sat,O
107322,1,of,O
107322,1,95,O
107322,1,%,O
107322,1,",",O
107322,1,ambulatory,O
107322,1,O2sat,O
107322,1,of,O
107322,1,85,O
107322,1,%,O
107322,1,),O
107322,1,",",O
107322,1,and,O
107322,1,also,O
107322,1,had,O
107322,1,cloudy,O
107322,1,urine,O
107322,1,.,O
107322,1,He,O
107322,1,was,O
107322,1,treated,O
107322,1,with,O
107322,1,Ciprofloxacin,B-Drug
107322,1,X2-3,O
107322,1,days,O
107322,1,for,O
107322,1,UTI,B-Reason
107322,1,",",O
107322,1,but,O
107322,1,because,O
107322,1,his,O
107322,1,hypoxia,O
107322,1,persisted,O
107322,1,and,O
107322,1,he,O
107322,1,had,O
107322,1,progressively,O
107322,1,worse,O
107322,1,dyspnea,O
107322,1,",",O
107322,1,he,O
107322,1,was,O
107322,1,admitted,O
107322,1,to,O
107322,1,[,O
107322,1,**Hospital1,O
107322,1,18**,O
107322,1,],O
107322,1,on,O
107322,1,[,O
107322,1,**7-27**,O
107322,1,],O
107322,1,.,O
107322,1,A,O
107322,1,new,O
107322,1,right,O
107322,1,middle,O
107322,1,lobe,O
107322,1,infiltrate,O
107322,1,was,O
107322,1,noted,O
107322,1,on,O
107322,1,CXR,O
107322,1,during,O
107322,1,that,O
107322,1,admission,O
107322,1,",",O
107322,1,which,O
107322,1,was,O
107322,1,felt,O
107322,1,to,O
107322,1,be,O
107322,1,an,O
107322,1,aspiration,B-Reason
107322,1,pneumonia,I-Reason
107322,1,.,O
107322,1,Patient,O
107322,1,was,O
107322,1,evaluated,O
107322,1,by,O
107322,1,Speech,O
107322,1,and,O
107322,1,Swallow,O
107322,1,who,O
107322,1,felt,O
107322,1,he,O
107322,1,had,O
107322,1,silent,O
107322,1,aspirations,O
107322,1,.,O
107322,1,He,O
107322,1,was,O
107322,1,treated,O
107322,1,with,O
107322,1,an,O
107322,1,8,O
107322,1,day,O
107322,1,course,O
107322,1,of,O
107322,1,broad,O
107322,1,antibiotics,B-Drug
107322,1,(,O
107322,1,Vancomycin,B-Drug
107322,1,and,O
107322,1,Zosyn,B-Drug
107322,1,),O
107322,1,which,O
107322,1,ended,O
107322,1,on,O
107322,1,[,O
107322,1,**2104-8-4**,O
107322,1,],O
107322,1,.,O
107322,1,He,O
107322,2,was,O
107322,2,discharged,O
107322,2,to,O
107322,2,[,O
107322,2,**Hospital3,O
107322,2,**,O
107322,2,],O
107322,2,on,O
107322,2,the,O
107322,2,20th,O
107322,2,",",O
107322,2,but,O
107322,2,on,O
107322,2,the,O
107322,2,21st,O
107322,2,he,O
107322,2,was,O
107322,2,sent,O
107322,2,to,O
107322,2,the,O
107322,2,[,O
107322,2,**Hospital6,O
107322,2,5016**,O
107322,2,],O
107322,2,because,O
107322,2,his,O
107322,2,O2,O
107322,2,sats,O
107322,2,were,O
107322,2,down,O
107322,2,in,O
107322,2,the,O
107322,2,80s,O
107322,2,.,O
107322,2,At,O
107322,2,the,O
107322,2,OSH,O
107322,2,",",O
107322,2,a,O
107322,2,CT,O
107322,2,chest,O
107322,2,was,O
107322,2,performed,O
107322,2,that,O
107322,2,showed,O
107322,2,bilateral,O
107322,2,pulmonary,O
107322,2,fibrosis,O
107322,2,with,O
107322,2,brochiectasic,O
107322,2,changes,O
107322,2,and,O
107322,2,a,O
107322,2,small,O
107322,2,acute,B-Reason
107322,2,infiltrate,I-Reason
107322,2,in,I-Reason
107322,2,the,I-Reason
107322,2,left,I-Reason
107322,2,upper,I-Reason
107322,2,lobe,I-Reason
107322,2,.,O
107322,2,Patient,O
107322,2,received,O
107322,2,4,O
107322,2,days,O
107322,2,of,O
107322,2,levofloxacin,B-Drug
107322,2,IV,O
107322,2,.,O
107322,2,On,O
107322,2,the,O
107322,2,24th,O
107322,2,",",O
107322,2,the,O
107322,2,patient,O
107322,2,and,O
107322,2,his,O
107322,2,family,O
107322,2,requested,O
107322,2,transfer,O
107322,2,to,O
107322,2,[,O
107322,2,**Hospital1,O
107322,2,18**,O
107322,2,],O
107322,2,for,O
107322,2,further,O
107322,2,management,O
107322,2,of,O
107322,2,his,O
107322,2,treatment,O
107322,2,because,O
107322,2,this,O
107322,2,is,O
107322,2,where,O
107322,2,he,O
107322,2,gets,O
107322,2,the,O
107322,2,majority,O
107322,2,of,O
107322,2,his,O
107322,2,treatment,O
107322,2,.,O
107322,2,.,O
107322,2,Of,O
107322,2,note,O
107322,2,",",O
107322,2,the,O
107322,2,CTA,O
107322,2,chest,O
107322,2,from,O
107322,2,[,O
107322,2,**7-15**,O
107322,2,],O
107322,2,states,O
107322,2,:,O
107322,2,``,O
107322,2,Extensive,O
107322,2,consolidation,O
107322,2,involving,O
107322,2,the,O
107322,2,left,O
107322,2,upper,O
107322,2,lobe,O
107322,2,",",O
107322,2,could,O
107322,2,represent,O
107322,2,infection,O
107322,2,.,O
107322,2,However,O
107322,2,",",O
107322,2,given,O
107322,2,the,O
107322,2,clinical,O
107322,2,history,O
107322,2,of,O
107322,2,elevated,O
107322,2,INR,O
107322,2,",",O
107322,2,hemoptysis,O
107322,2,",",O
107322,2,and,O
107322,2,lack,O
107322,2,of,O
107322,2,symptoms,O
107322,2,of,O
107322,2,pneumonia,O
107322,2,",",O
107322,2,this,O
107322,2,could,O
107322,2,represent,O
107322,2,pulmonary,O
107322,2,hemorrhage,O
107322,2,.,O
107322,2,'',O
107322,2,.,O
107322,2,Also,O
107322,2,",",O
107322,2,since,O
107322,2,the,O
107322,2,patient,O
107322,2,'s,O
107322,2,discharge,O
107322,2,from,O
107322,2,first,O
107322,2,admission,O
107322,2,",",O
107322,2,on,O
107322,2,[,O
107322,2,**7-20**,O
107322,2,],O
107322,2,there,O
107322,2,has,O
107322,2,been,O
107322,2,concerns,O
107322,2,regarding,O
107322,2,ongoing,O
107322,2,altered,O
107322,2,mental,O
107322,2,status,O
107322,2,.,O
107322,2,For,O
107322,2,a,O
107322,2,while,O
107322,2,",",O
107322,2,the,O
107322,2,patient,O
107322,2,'s,O
107322,2,wife,O
107322,2,had,O
107322,2,to,O
107322,2,have,O
107322,2,friends,O
107322,2,take,O
107322,2,turns,O
107322,2,supervising,O
107322,2,him,O
107322,2,at,O
107322,2,home,O
107322,2,when,O
107322,2,she,O
107322,2,was,O
107322,2,out,O
107322,2,.,O
107322,2,Geriatrics,O
107322,2,was,O
107322,2,involved,O
107322,2,during,O
107322,2,the,O
107322,2,patient,O
107322,2,'s,O
107322,2,last,O
107322,2,[,O
107322,2,**Hospital1,O
107322,2,18**,O
107322,2,],O
107322,2,admission,O
107322,2,for,O
107322,2,difficult,O
107322,2,to,O
107322,2,manage,O
107322,2,delirium,O
107322,2,which,O
107322,2,was,O
107322,2,felt,O
107322,2,somewhat,O
107322,2,more,O
107322,2,consistent,O
107322,2,with,O
107322,2,that,O
107322,2,of,O
107322,2,acute,O
107322,2,brain,O
107322,2,injury,O
107322,2,.,O
107322,2,Psychiatry,O
107322,2,at,O
107322,2,[,O
107322,2,**Hospital6,O
107322,2,5016**,O
107322,2,],O
107322,2,saw,O
107322,2,the,O
107322,2,patient,O
107322,2,during,O
107322,2,his,O
107322,2,current,O
107322,2,admission,O
107322,2,and,O
107322,2,felt,O
107322,2,he,O
107322,2,was,O
107322,2,delirious,O
107322,2,from,O
107322,2,ongoing,O
107322,2,hypoxia,O
107322,2,",",O
107322,2,and,O
107322,2,pulmonary,O
107322,2,disease,O
107322,2,.,O
107322,2,Prior,O
107322,2,to,O
107322,2,his,O
107322,2,presentation,O
107322,2,to,O
107322,2,[,O
107322,2,**Hospital1,O
107322,2,18**,O
107322,2,],O
107322,2,on,O
107322,2,[,O
107322,2,**7-15**,O
107322,2,],O
107322,2,",",O
107322,2,the,O
107322,2,patient,O
107322,2,had,O
107322,2,been,O
107322,2,functional,O
107322,2,and,O
107322,2,travelling,O
107322,2,through,O
107322,2,[,O
107322,2,**Country,O
107322,2,18084**,O
107322,2,],O
107322,2,where,O
107322,2,he,O
107322,2,climbed,O
107322,2,up,O
107322,2,to,O
107322,2,Edinburgh,O
107322,2,Castle,O
107322,2,.,O
107322,2,.,O
107322,2,Upon,O
107322,2,transfer,O
107322,2,to,O
107322,3,the,O
107322,3,[,O
107322,3,**Hospital1,O
107322,3,18**,O
107322,3,],O
107322,3,",",O
107322,3,the,O
107322,3,patient,O
107322,3,was,O
107322,3,stable,O
107322,3,.,O
107322,3,When,O
107322,3,interviewed,O
107322,3,",",O
107322,3,however,O
107322,3,",",O
107322,3,he,O
107322,3,was,O
107322,3,alert,O
107322,3,and,O
107322,3,oriented,O
107322,3,X2,O
107322,3,but,O
107322,3,not,O
107322,3,making,O
107322,3,much,O
107322,3,sense,O
107322,3,in,O
107322,3,his,O
107322,3,answers,O
107322,3,.,O
107322,3,When,O
107322,3,asked,O
107322,3,about,O
107322,3,his,O
107322,3,symptoms,O
107322,3,",",O
107322,3,he,O
107322,3,would,O
107322,3,talk,O
107322,3,about,O
107322,3,his,O
107322,3,coming,O
107322,3,from,O
107322,3,[,O
107322,3,**Location,O
107322,3,(,O
107322,3,un,O
107322,3,),O
107322,3,**,O
107322,3,],O
107322,3,many,O
107322,3,years,O
107322,3,ago,O
107322,3,.,O
107322,3,He,O
107322,3,did,O
107322,3,endorse,O
107322,3,trouble,O
107322,3,breathing,O
107322,3,and,O
107322,3,anxiety,O
107322,3,.,O
107322,3,The,O
107322,3,RN,O
107322,3,noted,O
107322,3,he,O
107322,3,coughed,O
107322,3,up,O
107322,3,mucous,O
107322,3,with,O
107322,3,blood,O
107322,3,.,O
107322,3,.,O
107322,3,Review,O
107322,3,of,O
107322,3,systems,O
107322,3,:,O
107322,3,Difficult,O
107322,3,to,O
107322,3,get,O
107322,3,an,O
107322,3,accurate,O
107322,3,ROS,O
107322,3,as,O
107322,3,patient,O
107322,3,'s,O
107322,3,responses,O
107322,3,do,O
107322,3,not,O
107322,3,make,O
107322,3,sense,O
107322,3,.,O
107322,3,Past,O
107322,3,Medical,O
107322,3,History,O
107322,3,:,O
107322,3,-,O
107322,3,Atrial,B-Reason
107322,3,fibrillation,I-Reason
107322,3,",",O
107322,3,chronic,O
107322,3,",",O
107322,3,on,O
107322,3,warfarin,B-Drug
107322,3,and,O
107322,3,beta,B-Drug
107322,3,blocker,I-Drug
107322,3,-,O
107322,3,History,O
107322,3,of,O
107322,3,CAD,O
107322,3,s/p,O
107322,3,MI,O
107322,3,in,O
107322,3,[,O
107322,3,**2088**,O
107322,3,],O
107322,3,and,O
107322,3,CABG,O
107322,3,(,O
107322,3,LIMA,O
107322,3,--,O
107322,3,>,O
107322,3,LAD,O
107322,3,",",O
107322,3,SVG,O
107322,3,--,O
107322,3,>,O
107322,3,RPDA-RPL,O
107322,3,",",O
107322,3,SVG,O
107322,3,--,O
107322,3,>,O
107322,3,LCX,O
107322,3,),O
107322,3,w/,O
107322,3,severe,O
107322,3,residual,O
107322,3,disease,O
107322,3,and,O
107322,3,inferior,O
107322,3,ischemia,O
107322,3,on,O
107322,3,stress,O
107322,3,testing,O
107322,3,",",O
107322,3,minimal,O
107322,3,exercise,O
107322,3,tolerance,O
107322,3,and,O
107322,3,BP,O
107322,3,drop,O
107322,3,during,O
107322,3,stress,O
107322,3,-,O
107322,3,Systolic,O
107322,3,heart,O
107322,3,failure,O
107322,3,",",O
107322,3,LVEF,O
107322,3,40-45,O
107322,3,%,O
107322,3,(,O
107322,3,[,O
107322,3,**4-/2104**,O
107322,3,],O
107322,3,),O
107322,3,-,O
107322,3,Chronic,O
107322,3,kidney,O
107322,3,disease,O
107322,3,",",O
107322,3,stage,O
107322,3,3,O
107322,3,-,O
107322,3,Hyperlipidemia,O
107322,3,on,O
107322,3,meds,O
107322,3,",",O
107322,3,LDL,O
107322,3,58,O
107322,3,(,O
107322,3,[,O
107322,3,**1-/2103**,O
107322,3,],O
107322,3,),O
107322,3,-,O
107322,3,Hypertension,O
107322,3,-,O
107322,3,AAA,O
107322,3,s/p,O
107322,3,endovascular,O
107322,3,repair,O
107322,3,in,O
107322,3,[,O
107322,3,**2102**,O
107322,3,],O
107322,3,",",O
107322,3,s/p,O
107322,3,L,O
107322,3,limb,O
107322,3,endovascular,O
107322,3,leak,O
107322,3,repair,O
107322,3,",",O
107322,3,now,O
107322,3,with,O
107322,3,decreasing,O
107322,3,aneurysm,O
107322,3,size,O
107322,3,on,O
107322,3,CT,O
107322,3,abd,O
107322,3,(,O
107322,3,63,O
107322,3,x,O
107322,3,62,O
107322,3,mm,O
107322,3,",",O
107322,3,[,O
107322,3,**2104-7-15**,O
107322,3,],O
107322,3,),O
107322,3,-,O
107322,3,Mitral,O
107322,3,regurgitation,O
107322,3,",",O
107322,3,2+,O
107322,3,(,O
107322,3,[,O
107322,3,**4-/2104**,O
107322,3,],O
107322,3,),O
107322,3,-,O
107322,3,History,O
107322,3,of,O
107322,3,chronic,O
107322,3,DOE,O
107322,3,",",O
107322,3,likely,O
107322,3,multifactorial,O
107322,3,-,O
107322,3,Depression,O
107322,3,-,O
107322,3,s/p,O
107322,3,appendectomy,O
107322,3,Social,O
107322,3,History,O
107322,3,:,O
107322,3,Lives,O
107322,3,at,O
107322,3,home,O
107322,3,with,O
107322,3,wife,O
107322,3,in,O
107322,3,[,O
107322,3,**Name2,O
107322,3,(,O
107322,3,NI,O
107322,3,),O
107322,3,**,O
107322,3,],O
107322,3,Hempshire,O
107322,3,Patient,O
107322,3,reports,O
107322,3,40,O
107322,3,year,O
107322,3,h/o,O
107322,3,smoking,O
107322,3,but,O
107322,3,quit,O
107322,3,~20y,O
107322,3,ago,O
107322,3,.,O
107322,3,H/o,O
107322,3,drinking,O
107322,3,[,O
107322,3,**2-18**,O
107322,3,],O
107322,3,pints,O
107322,3,of,O
107322,3,beer,O
107322,3,daily,O
107322,3,for,O
107322,3,nearly,O
107322,3,20,O
107322,3,years,O
107322,3,.,O
107322,3,Cut,O
107322,3,down,O
107322,3,3-4,O
107322,3,years,O
107322,3,ago,O
107322,3,",",O
107322,3,drinking,O
107322,3,one,O
107322,3,glass,O
107322,3,daily,O
107322,3,.,O
107322,4,Denies,O
107322,4,illicit,O
107322,4,drug,O
107322,4,use,O
107322,4,Family,O
107322,4,History,O
107322,4,:,O
107322,4,He,O
107322,4,was,O
107322,4,the,O
107322,4,youngest,O
107322,4,of,O
107322,4,10,O
107322,4,children,O
107322,4,and,O
107322,4,he,O
107322,4,has,O
107322,4,lost,O
107322,4,numerous,O
107322,4,siblings,O
107322,4,to,O
107322,4,heart,O
107322,4,disease,O
107322,4,.,O
107322,4,Some,O
107322,4,where,O
107322,4,young,O
107322,4,",",O
107322,4,in,O
107322,4,their,O
107322,4,40,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,s,O
107322,4,",",O
107322,4,and,O
107322,4,some,O
107322,4,where,O
107322,4,older,O
107322,4,.,O
107322,4,Both,O
107322,4,parents,O
107322,4,died,O
107322,4,of,O
107322,4,CVA,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,?,O
107322,4,s,O
107322,4,.,O
107322,4,Physical,O
107322,4,Exam,O
107322,4,:,O
107322,4,Vitals,O
107322,4,:,O
107322,4,T,O
107322,4,:,O
107322,4,afebrile,O
107322,4,BP:117/71,O
107322,4,P:76,O
107322,4,R:18,O
107322,4,O2:94,O
107322,4,%,O
107322,4,on,O
107322,4,4L,O
107322,4,General,O
107322,4,:,O
107322,4,Alert,O
107322,4,",",O
107322,4,oriented,O
107322,4,",",O
107322,4,no,O
107322,4,acute,O
107322,4,distress,O
107322,4,HEENT,O
107322,4,:,O
107322,4,Sclera,O
107322,4,anicteric,O
107322,4,",",O
107322,4,dry,O
107322,4,mouth,O
107322,4,",",O
107322,4,EOMI,O
107322,4,Neck,O
107322,4,:,O
107322,4,supple,O
107322,4,",",O
107322,4,JVP,O
107322,4,not,O
107322,4,elevated,O
107322,4,",",O
107322,4,no,O
107322,4,hepatojugular,O
107322,4,reflux,O
107322,4,Lungs,O
107322,4,:,O
107322,4,Expiratory,O
107322,4,crackles,O
107322,4,present,O
107322,4,in,O
107322,4,lower,O
107322,4,lung,O
107322,4,bases,O
107322,4,",",O
107322,4,L,O
107322,4,>,O
107322,4,R,O
107322,4,",",O
107322,4,no,O
107322,4,wheezing/rhonchi/rales,O
107322,4,CV,O
107322,4,:,O
107322,4,irregularly,O
107322,4,irregular,O
107322,4,.,O
107322,4,No,O
107322,4,murmurs/gallops/rubs,O
107322,4,Abdomen,O
107322,4,:,O
107322,4,soft,O
107322,4,",",O
107322,4,non-tender,O
107322,4,",",O
107322,4,non-distended,O
107322,4,",",O
107322,4,BS+,O
107322,4,Ext,O
107322,4,:,O
107322,4,Warm,O
107322,4,",",O
107322,4,well,O
107322,4,perfused,O
107322,4,",",O
107322,4,no,O
107322,4,peripheral,O
107322,4,edema,O
107322,4,",",O
107322,4,no,O
107322,4,cyanosis/ecchymosis,O
107322,4,.,O
107322,4,Pertinent,O
107322,4,Results,O
107322,4,:,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,GLUCOSE-77,O
107322,4,UREA,O
107322,4,N-23*,O
107322,4,CREAT-1.2,O
107322,4,SODIUM-144,O
107322,4,POTASSIUM-3.9,O
107322,4,CHLORIDE-110*,O
107322,4,TOTAL,O
107322,4,CO2-25,O
107322,4,ANION,O
107322,4,GAP-13,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,proBNP-,O
107322,4,[,O
107322,4,**Numeric,O
107322,4,Identifier,O
107322,4,18091**,O
107322,4,],O
107322,4,*,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,ALBUMIN-3.0*,O
107322,4,CALCIUM-9.1,O
107322,4,PHOSPHATE-3.7,O
107322,4,MAGNESIUM-2.1,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,WBC-5.7,O
107322,4,RBC-4.32*,O
107322,4,HGB-11.3*,O
107322,4,HCT-36.0*,O
107322,4,MCV-83,O
107322,4,MCH-26.2*,O
107322,4,MCHC-31.4,O
107322,4,RDW-19.2*,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,PLT,O
107322,4,COUNT-172,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,PT-36.5*,O
107322,4,PTT-36.9*,O
107322,4,INR,O
107322,4,(,O
107322,4,PT,O
107322,4,),O
107322,4,-3.8*,O
107322,4,[,O
107322,4,**2104-8-8**,O
107322,4,],O
107322,4,06:00PM,O
107322,4,ALT,O
107322,4,(,O
107322,4,SGPT,O
107322,4,),O
107322,4,-44*,O
107322,4,AST,O
107322,4,(,O
107322,4,SGOT,O
107322,4,),O
107322,4,-74*,O
107322,4,LD,O
107322,4,(,O
107322,4,LDH,O
107322,4,),O
107322,4,-392*,O
107322,4,ALK,O
107322,4,PHOS-95,O
107322,4,TOT,O
107322,4,BILI-1.5,O
107322,4,Brief,O
107322,4,Hospital,O
107322,4,Course,O
107322,4,:,O
107322,4,Mr.,O
107322,4,[,O
107322,4,**Known,O
107322,4,lastname,O
107322,4,**,O
107322,4,],O
107322,4,is,O
107322,4,a,O
107322,4,77,O
107322,4,year,O
107322,4,old,O
107322,4,man,O
107322,4,with,O
107322,4,CAD,O
107322,4,",",O
107322,4,CHF,O
107322,4,",",O
107322,4,who,O
107322,4,was,O
107322,4,admitted,O
107322,4,with,O
107322,4,hypoxia,O
107322,4,and,O
107322,4,AMS,O
107322,4,.,O
107322,4,Respiratory,O
107322,4,failure,O
107322,4,worsened,O
107322,4,during,O
107322,4,his,O
107322,4,hospital,O
107322,4,course,O
107322,4,despite,O
107322,4,treatments,O
107322,4,.,O
107322,4,He,O
107322,4,was,O
107322,4,made,O
107322,4,CMO,O
107322,4,and,O
107322,4,terminally,O
107322,4,extubated,O
107322,4,on,O
107322,4,[,O
107322,4,**2104-8-27**,O
107322,4,],O
107322,4,.,O
107322,4,The,O
107322,4,patient,O
107322,4,died,O
107322,4,at,O
107322,4,7:03pm,O
107322,4,.,O
107322,4,.,O
107322,4,.,O
107322,4,#,O
107322,4,HYPOXIA/DYSPNEA,O
107322,4,:,O
107322,4,The,O
107322,4,patient,O
107322,5,was,O
107322,5,transfered,O
107322,5,from,O
107322,5,OSH,O
107322,5,with,O
107322,5,hypoxia,O
107322,5,and,O
107322,5,dyspnea,O
107322,5,.,O
107322,5,We,O
107322,5,began,O
107322,5,treatment,O
107322,5,of,O
107322,5,LUL,B-Reason
107322,5,pneumonia,I-Reason
107322,5,empirically,O
107322,5,with,O
107322,5,levofloxacin,B-Drug
107322,5,(,O
107322,5,for,O
107322,5,CAP,B-Reason
107322,5,coverage,I-Reason
107322,5,),O
107322,5,",",O
107322,5,vancomycin,B-Drug
107322,5,(,O
107322,5,HAP,B-Reason
107322,5,coverage,I-Reason
107322,5,),O
107322,5,",",O
107322,5,and,O
107322,5,cefepime,B-Drug
107322,5,(,O
107322,5,for,O
107322,5,pseudomonal,B-Reason
107322,5,coverage,I-Reason
107322,5,),I-Reason
107322,5,.,O
107322,5,On,O
107322,5,the,O
107322,5,second,O
107322,5,day,O
107322,5,of,O
107322,5,hospitalization,O
107322,5,",",O
107322,5,levofloxacin,B-Drug
107322,5,was,O
107322,5,stopped,O
107322,5,and,O
107322,5,he,O
107322,5,was,O
107322,5,continued,O
107322,5,on,O
107322,5,vanc,B-Drug
107322,5,/,O
107322,5,cef,B-Drug
107322,5,for,O
107322,5,total,O
107322,5,of,O
107322,5,a,O
107322,5,14,O
107322,5,day,O
107322,5,course,O
107322,5,.,O
107322,5,Due,O
107322,5,to,O
107322,5,the,O
107322,5,fact,O
107322,5,that,O
107322,5,his,O
107322,5,pneumonia,O
107322,5,was,O
107322,5,not,O
107322,5,improving,O
107322,5,since,O
107322,5,his,O
107322,5,original,O
107322,5,diagnosis,O
107322,5,[,O
107322,5,**2104-7-15**,O
107322,5,],O
107322,5,",",O
107322,5,pulmonology,O
107322,5,was,O
107322,5,consulted,O
107322,5,.,O
107322,5,Urine,O
107322,5,legionella,O
107322,5,was,O
107322,5,negative,O
107322,5,",",O
107322,5,LDH,O
107322,5,was,O
107322,5,elevated,O
107322,5,at,O
107322,5,392,O
107322,5,.,O
107322,5,A,O
107322,5,CT,O
107322,5,of,O
107322,5,the,O
107322,5,Chest,O
107322,5,on,O
107322,5,[,O
107322,5,**8-9**,O
107322,5,],O
107322,5,showed,O
107322,5,marked,O
107322,5,worsening,O
107322,5,of,O
107322,5,nonspecific,O
107322,5,multifocal,O
107322,5,ground-glass,O
107322,5,opacities,O
107322,5,and,O
107322,5,consolidations,O
107322,5,predominantly,O
107322,5,involving,O
107322,5,the,O
107322,5,left,O
107322,5,upper,O
107322,5,",",O
107322,5,right,O
107322,5,upper,O
107322,5,",",O
107322,5,left,O
107322,5,lower,O
107322,5,and,O
107322,5,portions,O
107322,5,of,O
107322,5,the,O
107322,5,right,O
107322,5,lower,O
107322,5,lobes,O
107322,5,of,O
107322,5,infectious,O
107322,5,v.,O
107322,5,inflammatory,O
107322,5,v.,O
107322,5,hemorrhagic,O
107322,5,etiology,O
107322,5,.,O
107322,5,Bronchoscopy,O
107322,5,on,O
107322,5,[,O
107322,5,**8-14**,O
107322,5,],O
107322,5,was,O
107322,5,grossly,O
107322,5,normal,O
107322,5,",",O
107322,5,no,O
107322,5,signs,O
107322,5,of,O
107322,5,hemorrhage,O
107322,5,(,O
107322,5,only,O
107322,5,abnormality,O
107322,5,small,O
107322,5,nonobstructing,O
107322,5,membrane,O
107322,5,extending,O
107322,5,about,O
107322,5,one-third,O
107322,5,of,O
107322,5,the,O
107322,5,way,O
107322,5,into,O
107322,5,the,O
107322,5,airway,O
107322,5,lumen,O
107322,5,in,O
107322,5,the,O
107322,5,posterior,O
107322,5,segment,O
107322,5,of,O
107322,5,the,O
107322,5,left,O
107322,5,upper,O
107322,5,lobe,O
107322,5,),O
107322,5,.,O
107322,5,BAL,O
107322,5,showed,O
107322,5,hemosiderin-laden,O
107322,5,macrophages,O
107322,5,and,O
107322,5,multinucleated,O
107322,5,histiocytes,O
107322,5,and,O
107322,5,was,O
107322,5,negative,O
107322,5,for,O
107322,5,malignant,O
107322,5,cells,O
107322,5,",",O
107322,5,PCP,O
107322,5,",",O
107322,5,[,O
107322,5,**Name10,O
107322,5,(,O
107322,5,NameIs,O
107322,5,),O
107322,5,18092**,O
107322,5,],O
107322,5,",",O
107322,5,and,O
107322,5,CMV,O
107322,5,",",O
107322,5,and,O
107322,5,was,O
107322,5,significant,O
107322,5,only,O
107322,5,for,O
107322,5,1+,O
107322,5,PMNs,O
107322,5,and,O
107322,5,10-100K,O
107322,5,yeast,O
107322,5,",",O
107322,5,most,O
107322,5,likely,O
107322,5,colonizer,O
107322,5,),O
107322,5,.,O
107322,5,Blood,O
107322,5,cultures,O
107322,5,were,O
107322,5,negative,O
107322,5,x,O
107322,5,5,O
107322,5,",",O
107322,5,HIV,O
107322,5,was,O
107322,5,negative,O
107322,5,",",O
107322,5,aspergillus,O
107322,5,negative,O
107322,5,",",O
107322,5,hepatitis,O
107322,5,serologies,O
107322,5,were,O
107322,5,negative,O
107322,5,.,O
107322,5,Infectious,O
107322,5,w/u,O
107322,5,was,O
107322,5,significant,O
107322,5,only,O
107322,5,for,O
107322,5,a,O
107322,5,positive,O
107322,5,serum,O
107322,5,beta,O
107322,5,glucan,O
107322,5,(,O
107322,5,163,O
107322,5,),O
107322,5,",",O
107322,5,and,O
107322,5,at,O
107322,5,time,O
107322,5,of,O
107322,5,transfer,O
107322,5,to,O
107322,5,the,O
107322,5,MICU,O
107322,5,cryptococcus,O
107322,5,and,O
107322,5,quantiferon,O
107322,5,gold,O
107322,5,were,O
107322,5,pending,O
107322,5,.,O
107322,5,Inflammatory,O
107322,5,w/u,O
107322,5,negative,O
107322,5,for,O
107322,5,anti-GBM,O
107322,5,negative,O
107322,5,",",O
107322,5,complement,O
107322,5,normal,O
107322,5,",",O
107322,5,ANCA,O
107322,5,negative,O
107322,5,",",O
107322,5,ESR,O
107322,5,elevated,O
107322,5,at,O
107322,5,60,O
107322,5,.,O
107322,5,He,O
107322,5,completed,O
107322,5,a,O
107322,5,14,O
107322,5,day,O
107322,5,course,O
107322,5,of,O
107322,5,vanc,B-Drug
107322,6,/,O
107322,6,cef,B-Drug
107322,6,without,O
107322,6,improvement,O
107322,6,in,O
107322,6,pulmonary,O
107322,6,status,O
107322,6,.,O
107322,6,Repeat,O
107322,6,chest,O
107322,6,CT,O
107322,6,on,O
107322,6,[,O
107322,6,**8-17**,O
107322,6,],O
107322,6,showed,O
107322,6,interval,O
107322,6,progression,O
107322,6,of,O
107322,6,multifocal,O
107322,6,consolidations,O
107322,6,",",O
107322,6,likely,O
107322,6,representing,O
107322,6,infections,O
107322,6,",",O
107322,6,although,O
107322,6,inflammatory,O
107322,6,condition,O
107322,6,is,O
107322,6,a,O
107322,6,possibility,O
107322,6,as,O
107322,6,well,O
107322,6,as,O
107322,6,new,O
107322,6,small,O
107322,6,bilateral,O
107322,6,pleural,O
107322,6,effusions,O
107322,6,.,O
107322,6,He,O
107322,6,was,O
107322,6,again,O
107322,6,started,O
107322,6,on,O
107322,6,40,O
107322,6,mg,O
107322,6,IV,O
107322,6,lasix,B-Drug
107322,6,daily,O
107322,6,with,O
107322,6,appropriate,O
107322,6,diuresis,O
107322,6,.,O
107322,6,Infectious,O
107322,6,disease,O
107322,6,was,O
107322,6,consulted,O
107322,6,on,O
107322,6,[,O
107322,6,**8-21**,O
107322,6,],O
107322,6,and,O
107322,6,recommended,O
107322,6,VATS,O
107322,6,for,O
107322,6,definitive,O
107322,6,diagnosis,O
107322,6,as,O
107322,6,it,O
107322,6,was,O
107322,6,not,O
107322,6,felt,O
107322,6,that,O
107322,6,the,O
107322,6,underlying,O
107322,6,pulmonary,O
107322,6,process,O
107322,6,represented,O
107322,6,an,O
107322,6,infectious,O
107322,6,etiology,O
107322,6,",",O
107322,6,however,O
107322,6,he,O
107322,6,was,O
107322,6,not,O
107322,6,deemed,O
107322,6,to,O
107322,6,be,O
107322,6,a,O
107322,6,surgical,O
107322,6,candidate,O
107322,6,due,O
107322,6,to,O
107322,6,his,O
107322,6,many,O
107322,6,comorbidities,O
107322,6,.,O
107322,6,Per,O
107322,6,chest,O
107322,6,CT,O
107322,6,",",O
107322,6,there,O
107322,6,was,O
107322,6,concern,O
107322,6,that,O
107322,6,the,O
107322,6,ground,O
107322,6,glass,O
107322,6,opacities,O
107322,6,on,O
107322,6,repeat,O
107322,6,chest,O
107322,6,CT,O
107322,6,may,O
107322,6,represent,O
107322,6,usual,O
107322,6,interstitial,B-Reason
107322,6,pneumonitis,I-Reason
107322,6,",",O
107322,6,the,O
107322,6,treatment,O
107322,6,of,O
107322,6,which,O
107322,6,would,O
107322,6,be,O
107322,6,steroids,B-Drug
107322,6,.,O
107322,6,On,O
107322,6,[,O
107322,6,**8-21**,O
107322,6,],O
107322,6,he,O
107322,6,was,O
107322,6,started,O
107322,6,on,O
107322,6,empiric,O
107322,6,IV,O
107322,6,solumedrol,B-Drug
107322,6,80,O
107322,6,mg,O
107322,6,TID,O
107322,6,which,O
107322,6,was,O
107322,6,tapered,O
107322,6,to,O
107322,6,80,O
107322,6,mg,O
107322,6,IV,O
107322,6,BID,O
107322,6,on,O
107322,6,[,O
107322,6,**8-23**,O
107322,6,],O
107322,6,.,O
107322,6,Repeat,O
107322,6,CXR,O
107322,6,on,O
107322,6,[,O
107322,6,**8-24**,O
107322,6,],O
107322,6,showed,O
107322,6,no,O
107322,6,significant,O
107322,6,change,O
107322,6,from,O
107322,6,prior,O
107322,6,and,O
107322,6,plans,O
107322,6,were,O
107322,6,for,O
107322,6,steroid,B-Drug
107322,6,taper,O
107322,6,.,O
107322,6,Throughout,O
107322,6,hospital,O
107322,6,stay,O
107322,6,",",O
107322,6,Mr.,O
107322,6,[,O
107322,6,**Known,O
107322,6,lastname,O
107322,6,**,O
107322,6,],O
107322,6,was,O
107322,6,on,O
107322,6,supplementary,O
107322,6,O2,B-Drug
107322,6,as,O
107322,6,needed,O
107322,6,",",O
107322,6,incentive,O
107322,6,spirometry,O
107322,6,",",O
107322,6,and,O
107322,6,albuterol/ipratropium,B-Drug
107322,6,nebs,O
107322,6,.,O
107322,6,O2,O
107322,6,was,O
107322,6,weaned,O
107322,6,and,O
107322,6,sats,O
107322,6,were,O
107322,6,consistently,O
107322,6,in,O
107322,6,the,O
107322,6,low,O
107322,6,90s,O
107322,6,on,O
107322,6,room,O
107322,6,air,O
107322,6,and,O
107322,6,in,O
107322,6,the,O
107322,6,mid-high,O
107322,6,90s,O
107322,6,on,O
107322,6,2L,O
107322,6,O2,B-Drug
107322,6,NC,O
107322,6,.,O
107322,6,.,O
107322,6,#,O
107322,6,DELIRIUM,O
107322,6,:,O
107322,6,Patient,O
107322,6,came,O
107322,6,in,O
107322,6,with,O
107322,6,delirium,O
107322,6,",",O
107322,6,which,O
107322,6,he,O
107322,6,did,O
107322,6,not,O
107322,6,have,O
107322,6,at,O
107322,6,baseline,O
107322,6,(,O
107322,6,was,O
107322,6,travelling,O
107322,6,in,O
107322,6,[,O
107322,6,**Country,O
107322,6,18084**,O
107322,6,],O
107322,6,",",O
107322,6,hiking,O
107322,6,with,O
107322,6,family,O
107322,6,in,O
107322,6,[,O
107322,6,**Month,O
107322,6,(,O
107322,6,only,O
107322,6,),O
107322,6,216**,O
107322,6,],O
107322,6,),O
107322,6,.,O
107322,6,The,O
107322,6,likely,O
107322,6,etiology,O
107322,6,of,O
107322,6,his,O
107322,6,delirium,O
107322,6,was,O
107322,6,considered,O
107322,6,his,O
107322,6,ongoing,O
107322,6,infection,O
107322,6,+/-,O
107322,6,hospitalizations,O
107322,6,.,O
107322,6,UA,O
107322,6,was,O
107322,6,performed,O
107322,6,and,O
107322,6,was,O
107322,6,negative,O
107322,6,",",O
107322,6,a,O
107322,6,UCx,O
107322,6,showed,O
107322,6,no,O
107322,6,growth,O
107322,6,",",O
107322,6,which,O
107322,6,ruled,O
107322,6,out,O
107322,6,UTI,O
107322,6,as,O
107322,6,the,O
107322,6,cause,O
107322,6,of,O
107322,6,delirium,O
107322,6,.,O
107322,7,A,O
107322,7,CT,O
107322,7,head,O
107322,7,at,O
107322,7,last,O
107322,7,admission,O
107322,7,was,O
107322,7,negative,O
107322,7,for,O
107322,7,any,O
107322,7,intracranial,O
107322,7,process,O
107322,7,and,O
107322,7,repeat,O
107322,7,head,O
107322,7,CT,O
107322,7,on,O
107322,7,[,O
107322,7,**8-19**,O
107322,7,],O
107322,7,",",O
107322,7,obtained,O
107322,7,after,O
107322,7,an,O
107322,7,unwitnessed,O
107322,7,fall,O
107322,7,from,O
107322,7,bed,O
107322,7,with,O
107322,7,no,O
107322,7,signs,O
107322,7,of,O
107322,7,trauma,O
107322,7,again,O
107322,7,showed,O
107322,7,no,O
107322,7,acute,O
107322,7,intracranial,O
107322,7,process,O
107322,7,",",O
107322,7,again,O
107322,7,showed,O
107322,7,small,O
107322,7,vessel,O
107322,7,ischemic,O
107322,7,disease,O
107322,7,",",O
107322,7,unchanged,O
107322,7,old,O
107322,7,lacunar,O
107322,7,infarcts,O
107322,7,in,O
107322,7,the,O
107322,7,bilateral,O
107322,7,basal,O
107322,7,ganglia,O
107322,7,and,O
107322,7,extreme,O
107322,7,capsule,O
107322,7,",",O
107322,7,and,O
107322,7,prominent,O
107322,7,ventricles,O
107322,7,and,O
107322,7,sulci,O
107322,7,.,O
107322,7,On,O
107322,7,admission,O
107322,7,he,O
107322,7,was,O
107322,7,initially,O
107322,7,given,O
107322,7,Olanzapine,B-Drug
107322,7,5mg,O
107322,7,po,O
107322,7,q6h,O
107322,7,PRN,O
107322,7,agitation,B-Reason
107322,7,and,O
107322,7,haldol,B-Drug
107322,7,.,O
107322,7,Geriatrics,O
107322,7,follwoed,O
107322,7,the,O
107322,7,patient,O
107322,7,for,O
107322,7,management,O
107322,7,of,O
107322,7,his,O
107322,7,persistent,O
107322,7,delerium,O
107322,7,and,O
107322,7,sundowning,O
107322,7,and,O
107322,7,per,O
107322,7,their,O
107322,7,recommendations,O
107322,7,olanzapine,B-Drug
107322,7,was,O
107322,7,swithced,O
107322,7,to,O
107322,7,seroquel,B-Drug
107322,7,and,O
107322,7,uptitrated,O
107322,7,to,O
107322,7,12.5,O
107322,7,QAM,O
107322,7,and,O
107322,7,37.5,O
107322,7,QHS,O
107322,7,with,O
107322,7,PRN,O
107322,7,seroquel,B-Drug
107322,7,and,O
107322,7,haldol,B-Drug
107322,7,.,O
107322,7,Delerium,O
107322,7,was,O
107322,7,also,O
107322,7,managed,O
107322,7,with,O
107322,7,soft,O
107322,7,restraints,O
107322,7,and,O
107322,7,cage,O
107322,7,bed,O
107322,7,in,O
107322,7,order,O
107322,7,to,O
107322,7,keep,O
107322,7,Mr.,O
107322,7,[,O
107322,7,**Known,O
107322,7,lastname,O
107322,7,**,O
107322,7,],O
107322,7,from,O
107322,7,injuring,O
107322,7,staff,O
107322,7,and,O
107322,7,pulling,O
107322,7,out,O
107322,7,his,O
107322,7,lines,O
107322,7,.,O
107322,7,Neurology,O
107322,7,was,O
107322,7,consulted,O
107322,7,on,O
107322,7,admission,O
107322,7,and,O
107322,7,initially,O
107322,7,felt,O
107322,7,his,O
107322,7,confusion,O
107322,7,was,O
107322,7,due,O
107322,7,to,O
107322,7,his,O
107322,7,underlying,O
107322,7,pulmonary,O
107322,7,process,O
107322,7,.,O
107322,7,However,O
107322,7,",",O
107322,7,when,O
107322,7,he,O
107322,7,failed,O
107322,7,to,O
107322,7,improve,O
107322,7,despite,O
107322,7,antibiotics,O
107322,7,and,O
107322,7,no,O
107322,7,source,O
107322,7,of,O
107322,7,infection,O
107322,7,was,O
107322,7,identified,O
107322,7,",",O
107322,7,they,O
107322,7,were,O
107322,7,reconsulted,O
107322,7,on,O
107322,7,[,O
107322,7,**8-21**,O
107322,7,],O
107322,7,and,O
107322,7,recommended,O
107322,7,LP,O
107322,7,",",O
107322,7,MRI,O
107322,7,w/,O
107322,7,and,O
107322,7,w/o,O
107322,7,contrast,O
107322,7,",",O
107322,7,and,O
107322,7,EEG,O
107322,7,due,O
107322,7,to,O
107322,7,concern,O
107322,7,for,O
107322,7,limibic,O
107322,7,encephalitis,O
107322,7,vs.,O
107322,7,paraneoplastic,O
107322,7,process,O
107322,7,vs.,O
107322,7,temporal,O
107322,7,lobe,O
107322,7,epilepsy,O
107322,7,.,O
107322,7,Patient,O
107322,7,is,O
107322,7,not,O
107322,7,a,O
107322,7,candidate,O
107322,7,for,O
107322,7,MRI,O
107322,7,due,O
107322,7,to,O
107322,7,his,O
107322,7,Zenith,O
107322,7,AAA,O
107322,7,stent,O
107322,7,graft,O
107322,7,.,O
107322,7,At,O
107322,7,the,O
107322,7,time,O
107322,7,of,O
107322,7,transfer,O
107322,7,LP,O
107322,7,had,O
107322,7,so,O
107322,7,far,O
107322,7,shown,O
107322,7,normal,O
107322,7,glucose,O
107322,7,",",O
107322,7,protein,O
107322,7,",",O
107322,7,and,O
107322,7,WBC,O
107322,7,",",O
107322,7,no,O
107322,7,organisms,O
107322,7,on,O
107322,7,Gram,O
107322,7,stain,O
107322,7,",",O
107322,7,no,O
107322,7,growth,O
107322,7,on,O
107322,7,preliminary,O
107322,7,bacterial,O
107322,7,",",O
107322,7,fungal,O
107322,7,",",O
107322,7,and,O
107322,7,acid,O
107322,7,fast,O
107322,7,cultures,O
107322,7,",",O
107322,7,negative,O
107322,7,cryptococcal,O
107322,7,antigen,O
107322,7,.,O
107322,7,CSF,O
107322,7,HSV,O
107322,7,and,O
107322,7,VDRL,O
107322,7,pending,O
107322,7,at,O
107322,7,time,O
107322,7,of,O
107322,7,transfer,O
107322,7,.,O
107322,7,Anti-,O
107322,7,[,O
107322,7,**Doctor,O
107322,7,Last,O
107322,7,Name,O
107322,7,**,O
107322,7,],O
107322,7,antibodies,O
107322,7,were,O
107322,7,negative,O
107322,7,.,O
107322,7,Serum,O
107322,7,RPR,O
107322,7,and,O
107322,7,[,O
107322,7,**Location,O
107322,7,(,O
107322,7,un,O
107322,7,),O
107322,7,**,O
107322,7,],O
107322,8,-,O
107322,8,[,O
107322,8,**Location,O
107322,8,(,O
107322,8,un,O
107322,8,),O
107322,8,**,O
107322,8,],O
107322,8,antibody,O
107322,8,panel,O
107322,8,",",O
107322,8,and,O
107322,8,"1,25",O
107322,8,vitamin,O
107322,8,D,O
107322,8,were,O
107322,8,pending,O
107322,8,.,O
107322,8,Patient,O
107322,8,was,O
107322,8,also,O
107322,8,undergoing,O
107322,8,EEG,O
107322,8,monitoring,O
107322,8,at,O
107322,8,the,O
107322,8,time,O
107322,8,of,O
107322,8,transfer,O
107322,8,.,O
107322,8,.,O
107322,8,#,O
107322,8,CHF,O
107322,8,:,O
107322,8,The,O
107322,8,patient,O
107322,8,has,O
107322,8,a,O
107322,8,history,O
107322,8,of,O
107322,8,CHF,O
107322,8,(,O
107322,8,EF,O
107322,8,40-45,O
107322,8,%,O
107322,8,per,O
107322,8,TTE,O
107322,8,done,O
107322,8,in,O
107322,8,[,O
107322,8,**4-/2104**,O
107322,8,],O
107322,8,),O
107322,8,and,O
107322,8,his,O
107322,8,CXR,O
107322,8,has,O
107322,8,presence,O
107322,8,of,O
107322,8,some,O
107322,8,mild,B-Reason
107322,8,pulmonary,I-Reason
107322,8,edema,I-Reason
107322,8,.,O
107322,8,He,O
107322,8,was,O
107322,8,initially,O
107322,8,continued,O
107322,8,on,O
107322,8,his,O
107322,8,home,O
107322,8,Lasix,B-Drug
107322,8,40,O
107322,8,mg,O
107322,8,po,O
107322,8,qd,O
107322,8,for,B-Reason
107322,8,CHF,I-Reason
107322,8,management,I-Reason
107322,8,",",O
107322,8,and,O
107322,8,medical,O
107322,8,management,O
107322,8,was,O
107322,8,continued,O
107322,8,with,O
107322,8,continued,O
107322,8,Carvedilol,B-Drug
107322,8,and,O
107322,8,Losartan,B-Drug
107322,8,.,O
107322,8,His,O
107322,8,lasix,B-Drug
107322,8,was,O
107322,8,discontinued,O
107322,8,for,O
107322,8,several,O
107322,8,days,O
107322,8,due,O
107322,8,to,O
107322,8,worsening,O
107322,8,delerium,O
107322,8,and,O
107322,8,no,O
107322,8,IV,O
107322,8,access,O
107322,8,and,O
107322,8,NPO,O
107322,8,status,O
107322,8,.,O
107322,8,Repeat,O
107322,8,chest,O
107322,8,CT,O
107322,8,on,O
107322,8,It,O
107322,8,was,O
107322,8,restarted,O
107322,8,intermittently,O
107322,8,at,O
107322,8,40,O
107322,8,mg,O
107322,8,[,O
107322,8,**Hospital1,O
107322,8,**,O
107322,8,],O
107322,8,.,O
107322,8,On,O
107322,8,[,O
107322,8,**8-19**,O
107322,8,],O
107322,8,a,O
107322,8,loud,O
107322,8,MR,O
107322,8,murmur,O
107322,8,was,O
107322,8,noted,O
107322,8,on,O
107322,8,physical,O
107322,8,exam,O
107322,8,and,O
107322,8,repeat,O
107322,8,TTE,O
107322,8,was,O
107322,8,poor,O
107322,8,quality,O
107322,8,and,O
107322,8,showed,O
107322,8,EF,O
107322,8,of,O
107322,8,30-35,O
107322,8,%,O
107322,8,",",O
107322,8,question,O
107322,8,of,O
107322,8,worsening,O
107322,8,MR,O
107322,8,",",O
107322,8,and,O
107322,8,antero/anterolateral,O
107322,8,hypokinesis,O
107322,8,.,O
107322,8,.,O
107322,8,#,O
107322,8,CAD,B-Reason
107322,8,with,I-Reason
107322,8,h/o,I-Reason
107322,8,MI,I-Reason
107322,8,:,O
107322,8,Isosorbide,B-Drug
107322,8,Mononitrate,I-Drug
107322,8,ER,I-Drug
107322,8,30mg,O
107322,8,daily,O
107322,8,and,O
107322,8,ASA,B-Drug
107322,8,were,O
107322,8,held,O
107322,8,the,O
107322,8,day,O
107322,8,after,O
107322,8,admission,O
107322,8,for,O
107322,8,systolic,O
107322,8,blood,O
107322,8,pressures,O
107322,8,in,O
107322,8,the,O
107322,8,low,O
107322,8,100s,O
107322,8,",",O
107322,8,some,O
107322,8,bloody,O
107322,8,sputum,O
107322,8,and,O
107322,8,supratherapeutic,O
107322,8,INR,O
107322,8,(,O
107322,8,3.8,O
107322,8,on,O
107322,8,admission,O
107322,8,),O
107322,8,.,O
107322,8,He,O
107322,8,was,O
107322,8,a,O
107322,8,poor,O
107322,8,historian,O
107322,8,and,O
107322,8,intermittently,O
107322,8,[,O
107322,8,**Month/Day,O
107322,8,(,O
107322,8,1,O
107322,8,),O
107322,8,12861**,O
107322,8,],O
107322,8,substernal,O
107322,8,chest,O
107322,8,pain,O
107322,8,.,O
107322,8,EKGs,O
107322,8,demonstrated,O
107322,8,TWI,O
107322,8,in,O
107322,8,the,O
107322,8,anterior,O
107322,8,",",O
107322,8,anterolateral,O
107322,8,",",O
107322,8,and,O
107322,8,inferolateral,O
107322,8,leads,O
107322,8,.,O
107322,8,Troponins,O
107322,8,were,O
107322,8,elevated,O
107322,8,at,O
107322,8,0.07,O
107322,8,to,O
107322,8,0.1,O
107322,8,with,O
107322,8,normal,O
107322,8,CK-MB,O
107322,8,and,O
107322,8,cardiology,O
107322,8,was,O
107322,8,consulted,O
107322,8,and,O
107322,8,felt,O
107322,8,this,O
107322,8,was,O
107322,8,most,O
107322,8,likely,O
107322,8,demand,B-Reason
107322,8,ischemia,I-Reason
107322,8,so,O
107322,8,he,O
107322,8,continued,O
107322,8,on,O
107322,8,medical,O
107322,8,management,O
107322,8,",",O
107322,8,Asa,B-Drug
107322,8,was,O
107322,8,restarted,O
107322,8,",",O
107322,8,and,O
107322,8,he,O
107322,8,was,O
107322,8,placed,O
107322,8,on,O
107322,8,carvedilol,B-Drug
107322,8,and,O
107322,8,[,O
107322,8,**Last,O
107322,8,Name,O
107322,8,(,O
107322,8,un,O
107322,8,),O
107322,8,**,O
107322,8,],O
107322,8,(,O
107322,8,[,O
107322,8,**Last,O
107322,8,Name,O
107322,8,(,O
107322,8,un,O
107322,8,),O
107322,8,**,O
107322,8,],O
107322,8,until,O
107322,8,[,O
107322,8,**8-18**,O
107322,8,],O
107322,8,when,O
107322,8,his,O
107322,8,Cr,O
107322,8,bumped,O
107322,8,.,O
107322,8,),O
107322,9,On,O
107322,9,the,O
107322,9,morning,O
107322,9,of,O
107322,9,transfer,O
107322,9,",",O
107322,9,Mr.,O
107322,9,[,O
107322,9,**Known,O
107322,9,lastname,O
107322,9,**,O
107322,9,],O
107322,9,[,O
107322,9,**Last,O
107322,9,Name,O
107322,9,(,O
107322,9,Titles,O
107322,9,),O
107322,9,12861**,O
107322,9,],O
107322,9,[,O
107322,9,**4-24**,O
107322,9,],O
107322,9,substernal,O
107322,9,chest,O
107322,9,pressure,O
107322,9,",",O
107322,9,as,O
107322,9,he,O
107322,9,had,O
107322,9,intermittently,O
107322,9,reported,O
107322,9,throughout,O
107322,9,hospitalization,O
107322,9,and,O
107322,9,cardiac,O
107322,9,enzymes,O
107322,9,were,O
107322,9,again,O
107322,9,checked,O
107322,9,and,O
107322,9,showed,O
107322,9,troponin,O
107322,9,0.02,O
107322,9,(,O
107322,9,down,O
107322,9,from,O
107322,9,prior,O
107322,9,),O
107322,9,and,O
107322,9,ECG,O
107322,9,showed,O
107322,9,no,O
107322,9,significant,O
107322,9,change,O
107322,9,from,O
107322,9,baseline,O
107322,9,.,O
107322,9,.,O
107322,9,#,O
107322,9,AFIB,B-Reason
107322,9,:,O
107322,9,Patient,O
107322,9,was,O
107322,9,rate,O
107322,9,controlled,O
107322,9,on,O
107322,9,admission,O
107322,9,and,O
107322,9,remained,O
107322,9,irregularly,O
107322,9,irregular,O
107322,9,throughout,O
107322,9,his,O
107322,9,hospital,O
107322,9,course,O
107322,9,.,O
107322,9,Patient,O
107322,9,had,O
107322,9,an,O
107322,9,elevated,O
107322,9,INR,O
107322,9,(,O
107322,9,3.8,O
107322,9,),O
107322,9,on,O
107322,9,admission,O
107322,9,with,O
107322,9,no,O
107322,9,evidence,O
107322,9,of,O
107322,9,acute,O
107322,9,bleed,O
107322,9,",",O
107322,9,so,O
107322,9,coumadin,B-Drug
107322,9,was,O
107322,9,held,O
107322,9,but,O
107322,9,rate,B-Reason
107322,9,control,I-Reason
107322,9,was,O
107322,9,continued,O
107322,9,with,O
107322,9,carvedilol,B-Drug
107322,9,.,O
107322,9,His,O
107322,9,carvedilol,B-Drug
107322,9,dose,O
107322,9,was,O
107322,9,stopped,O
107322,9,and,O
107322,9,restarted,O
107322,9,after,O
107322,9,he,O
107322,9,developed,O
107322,9,an,O
107322,9,episode,O
107322,9,of,O
107322,9,A.fib,O
107322,9,with,O
107322,9,RVR,O
107322,9,on,O
107322,9,[,O
107322,9,**8-13**,O
107322,9,],O
107322,9,.,O
107322,9,INR,O
107322,9,trended,O
107322,9,down,O
107322,9,and,O
107322,9,coumadin,B-Drug
107322,9,was,O
107322,9,again,O
107322,9,started,O
107322,9,on,O
107322,9,[,O
107322,9,**8-14**,O
107322,9,],O
107322,9,at,O
107322,9,a,O
107322,9,low,O
107322,9,dose,O
107322,9,of,O
107322,9,2,O
107322,9,mg,O
107322,9,daily,O
107322,9,.,O
107322,9,It,O
107322,9,was,O
107322,9,deemed,O
107322,9,to,O
107322,9,be,O
107322,9,safely,O
107322,9,stopped,O
107322,9,on,O
107322,9,[,O
107322,9,**8-16**,O
107322,9,],O
107322,9,in,O
107322,9,preparation,O
107322,9,for,O
107322,9,G-J,O
107322,9,tube,O
107322,9,placement,O
107322,9,in,O
107322,9,IR,O
107322,9,",",O
107322,9,as,O
107322,9,the,O
107322,9,patient,O
107322,9,had,O
107322,9,no,O
107322,9,reported,O
107322,9,history,O
107322,9,of,O
107322,9,stroke,O
107322,9,",",O
107322,9,and,O
107322,9,patient,O
107322,9,was,O
107322,9,given,O
107322,9,one,O
107322,9,dose,O
107322,9,of,O
107322,9,1,O
107322,9,mg,O
107322,9,of,O
107322,9,IV,O
107322,9,vitamin,B-Drug
107322,9,K,I-Drug
107322,9,on,O
107322,9,[,O
107322,9,**9-1**,O
107322,9,],O
107322,9,and,O
107322,9,[,O
107322,9,**8-22**,O
107322,9,],O
107322,9,(,O
107322,9,3,O
107322,9,mg,O
107322,9,total,O
107322,9,),O
107322,9,.,O
107322,9,Warfarin,B-Drug
107322,9,has,O
107322,9,been,O
107322,9,held,O
107322,9,since,O
107322,9,[,O
107322,9,**8-18**,O
107322,9,],O
107322,9,.,O
107322,9,.,O
107322,9,#,O
107322,9,HTN,B-Reason
107322,9,:,O
107322,9,Pt,O
107322,9,has,O
107322,9,a,O
107322,9,history,O
107322,9,of,O
107322,9,HTN,O
107322,9,.,O
107322,9,We,O
107322,9,continued,O
107322,9,home,O
107322,9,Losartan,B-Drug
107322,9,100,O
107322,9,mg,O
107322,9,Tablet,O
107322,9,until,O
107322,9,[,O
107322,9,**8-18**,O
107322,9,],O
107322,9,when,O
107322,9,Cr,O
107322,9,bumped,O
107322,9,.,O
107322,9,.,O
107322,9,#,O
107322,9,FEN,O
107322,9,:,O
107322,9,During,O
107322,9,previous,O
107322,9,hospitalizations,O
107322,9,",",O
107322,9,patient,O
107322,9,was,O
107322,9,evaluated,O
107322,9,by,O
107322,9,speech,O
107322,9,and,O
107322,9,swallow,O
107322,9,who,O
107322,9,thought,O
107322,9,he,O
107322,9,might,O
107322,9,be,O
107322,9,having,O
107322,9,silent,O
107322,9,aspiration,O
107322,9,and,O
107322,9,recommended,O
107322,9,soft,O
107322,9,diet,O
107322,9,and,O
107322,9,nectar,O
107322,9,thick,O
107322,9,fluids,O
107322,9,with,O
107322,9,monitoring,O
107322,9,when,O
107322,9,taking,O
107322,9,in,O
107322,9,by,O
107322,9,mouth,O
107322,9,food,O
107322,9,and,O
107322,9,medications,O
107322,9,.,O
107322,9,We,O
107322,9,continued,O
107322,9,soft,O
107322,9,diet,O
107322,9,and,O
107322,9,nectar,O
107322,9,thick,O
107322,9,fluid,O
107322,9,with,O
107322,9,aspiration,O
107322,9,precautions,O
107322,9,.,O
107322,9,Video,O
107322,9,swallow,O
107322,9,on,O
107322,9,[,O
107322,9,**8-11**,O
107322,9,],O
107322,10,showed,O
107322,10,aspiration,O
107322,10,of,O
107322,10,all,O
107322,10,consistencies,O
107322,10,and,O
107322,10,he,O
107322,10,was,O
107322,10,made,O
107322,10,NPO,O
107322,10,.,O
107322,10,Repeat,O
107322,10,video,O
107322,10,swallow,O
107322,10,on,O
107322,10,[,O
107322,10,**8-15**,O
107322,10,],O
107322,10,again,O
107322,10,showed,O
107322,10,florid,O
107322,10,aspiration,O
107322,10,.,O
107322,10,On,O
107322,10,[,O
107322,10,**8-21**,O
107322,10,],O
107322,10,he,O
107322,10,was,O
107322,10,allowed,O
107322,10,to,O
107322,10,take,O
107322,10,sips,O
107322,10,and,O
107322,10,eat,O
107322,10,a,O
107322,10,dysphagia,O
107322,10,diet,O
107322,10,because,O
107322,10,he,O
107322,10,had,O
107322,10,been,O
107322,10,NPO,O
107322,10,for,O
107322,10,10,O
107322,10,days,O
107322,10,",",O
107322,10,had,O
107322,10,poor,O
107322,10,IV,O
107322,10,access,O
107322,10,",",O
107322,10,and,O
107322,10,had,O
107322,10,not,O
107322,10,tolerated,O
107322,10,multiple,O
107322,10,attempts,O
107322,10,at,O
107322,10,dobhoff,O
107322,10,placement,O
107322,10,on,O
107322,10,the,O
107322,10,floor,O
107322,10,and,O
107322,10,G-J,O
107322,10,placement,O
107322,10,in,O
107322,10,the,O
107322,10,IR,O
107322,10,suite,O
107322,10,.,O
107322,10,It,O
107322,10,was,O
107322,10,also,O
107322,10,felt,O
107322,10,that,O
107322,10,his,O
107322,10,underlying,O
107322,10,lung,O
107322,10,process,O
107322,10,was,O
107322,10,due,O
107322,10,to,O
107322,10,a,O
107322,10,significantly,O
107322,10,more,O
107322,10,severe,O
107322,10,process,O
107322,10,than,O
107322,10,aspiration,O
107322,10,alone,O
107322,10,.,O
107322,10,He,O
107322,10,was,O
107322,10,also,O
107322,10,started,O
107322,10,on,O
107322,10,PPN,O
107322,10,on,O
107322,10,the,O
107322,10,evening,O
107322,10,of,O
107322,10,[,O
107322,10,**8-22**,O
107322,10,],O
107322,10,and,O
107322,10,received,O
107322,10,intermittent,O
107322,10,PPN,O
107322,10,.,O
107322,10,On,O
107322,10,the,O
107322,10,evening,O
107322,10,of,O
107322,10,transfer,O
107322,10,he,O
107322,10,was,O
107322,10,permitted,O
107322,10,to,O
107322,10,receive,O
107322,10,supervised,O
107322,10,milkshake,O
107322,10,spoon-feeding,O
107322,10,administered,O
107322,10,at,O
107322,10,bedside,O
107322,10,by,O
107322,10,his,O
107322,10,daughter,O
107322,10,.,O
107322,10,#,O
107322,10,Hypernatremia,B-ADE
107322,10,:,O
107322,10,On,O
107322,10,[,O
107322,10,**8-21**,O
107322,10,],O
107322,10,the,O
107322,10,patient,O
107322,10,developed,O
107322,10,hypernatremia,O
107322,10,to,O
107322,10,the,O
107322,10,140s,O
107322,10,with,O
107322,10,a,O
107322,10,max,O
107322,10,of,O
107322,10,153,O
107322,10,on,O
107322,10,[,O
107322,10,**8-22**,O
107322,10,],O
107322,10,in,O
107322,10,the,O
107322,10,setting,O
107322,10,of,O
107322,10,IV,O
107322,10,lasix,B-Drug
107322,10,followed,O
107322,10,by,O
107322,10,no,O
107322,10,IV,O
107322,10,access,O
107322,10,.,O
107322,10,He,O
107322,10,was,O
107322,10,spoon,O
107322,10,fed,O
107322,10,water,O
107322,10,and,O
107322,10,intermittently,O
107322,10,received,O
107322,10,up,O
107322,10,D5W,O
107322,10,with,O
107322,10,improvement,O
107322,10,in,O
107322,10,his,O
107322,10,Na,O
107322,10,to,O
107322,10,144,O
107322,10,on,O
107322,10,the,O
107322,10,day,O
107322,10,of,O
107322,10,transfer,O
107322,10,(,O
107322,10,[,O
107322,10,**8-24**,O
107322,10,],O
107322,10,),O
107322,10,.,O
107322,10,#,O
107322,10,ARF,B-ADE
107322,10,:,O
107322,10,On,O
107322,10,[,O
107322,10,**8-18**,O
107322,10,],O
107322,10,the,O
107322,10,patient,O
107322,10,developed,O
107322,10,a,O
107322,10,Cr,O
107322,10,bump,O
107322,10,to,O
107322,10,1.4,O
107322,10,in,O
107322,10,the,O
107322,10,setting,O
107322,10,of,O
107322,10,lasix,B-Drug
107322,10,administration,O
107322,10,.,O
107322,10,A,O
107322,10,true,O
107322,10,vanc,B-Drug
107322,10,trough,O
107322,10,the,O
107322,10,following,O
107322,10,morning,O
107322,10,was,O
107322,10,elevated,O
107322,10,at,O
107322,10,42,O
107322,10,.,O
107322,10,Vancomycin,B-Drug
107322,10,was,O
107322,10,d/c,O
107322,10,'d,O
107322,10,and,O
107322,10,the,O
107322,10,patient,O
107322,10,was,O
107322,10,hydrated,O
107322,10,with,O
107322,10,D51/2NS,B-Drug
107322,10,.,O
107322,10,His,O
107322,10,creatinine,O
107322,10,remained,O
107322,10,elevated,O
107322,10,",",O
107322,10,FeNa,O
107322,10,was,O
107322,10,<,O
107322,10,0.1,O
107322,10,%,O
107322,10,on,O
107322,10,[,O
107322,10,**8-24**,O
107322,10,],O
107322,10,",",O
107322,10,and,O
107322,10,his,O
107322,10,[,O
107322,10,**Last,O
107322,10,Name,O
107322,10,(,O
107322,10,un,O
107322,10,),O
107322,10,**,O
107322,10,],O
107322,10,and,O
107322,10,lasix,B-Drug
107322,10,continued,O
107322,10,to,O
107322,10,be,O
107322,10,held,O
107322,10,until,O
107322,10,the,O
107322,10,patient,O
107322,10,triggered,O
107322,10,on,O
107322,10,the,O
107322,10,evening,O
107322,10,of,O
107322,10,[,O
107322,10,**8-24**,O
107322,10,],O
107322,10,",",O
107322,10,prompting,O
107322,10,him,O
107322,10,to,O
107322,10,receive,O
107322,10,40,O
107322,10,mg,O
107322,10,of,O
107322,10,IV,O
107322,10,lasix,B-Drug
107322,10,prior,O
107322,10,to,O
107322,10,transfer,O
107322,10,to,O
107322,10,the,O
107322,10,MICU,O
107322,10,.,O
107322,10,#,O
107322,11,Rash,O
107322,11,:,O
107322,11,On,O
107322,11,admission,O
107322,11,the,O
107322,11,patient,O
107322,11,was,O
107322,11,noted,O
107322,11,to,O
107322,11,have,O
107322,11,a,O
107322,11,mild,O
107322,11,petechial,O
107322,11,rash,O
107322,11,and,O
107322,11,on,O
107322,11,[,O
107322,11,**8-12**,O
107322,11,],O
107322,11,the,O
107322,11,patient,O
107322,11,the,O
107322,11,rash,O
107322,11,was,O
107322,11,notably,O
107322,11,brightly,O
107322,11,erythematous,O
107322,11,",",O
107322,11,purpuric,O
107322,11,",",O
107322,11,confluent,O
107322,11,",",O
107322,11,and,O
107322,11,morbiliform,O
107322,11,rash,O
107322,11,and,O
107322,11,extended,O
107322,11,to,O
107322,11,all,O
107322,11,four,O
107322,11,extremities,O
107322,11,and,O
107322,11,his,O
107322,11,back,O
107322,11,.,O
107322,11,He,O
107322,11,has,O
107322,11,a,O
107322,11,concurrent,O
107322,11,eosinophilia,O
107322,11,(,O
107322,11,14.3,O
107322,11,%,O
107322,11,),O
107322,11,.,O
107322,11,Biopsy,O
107322,11,was,O
107322,11,consistent,O
107322,11,with,O
107322,11,leukocytoclastic,O
107322,11,vaculitis,O
107322,11,.,O
107322,11,Ddx,O
107322,11,included,O
107322,11,vasculitis,O
107322,11,vs.,O
107322,11,drug,O
107322,11,reaction,O
107322,11,.,O
107322,11,He,O
107322,11,had,O
107322,11,started,O
107322,11,cefepime,B-Drug
107322,11,3-4,O
107322,11,days,O
107322,11,prior,O
107322,11,to,O
107322,11,the,O
107322,11,rash,O
107322,11,.,O
107322,11,He,O
107322,11,was,O
107322,11,continued,O
107322,11,on,O
107322,11,cefepime,B-Drug
107322,11,and,O
107322,11,the,O
107322,11,rash,O
107322,11,resolved,O
107322,11,as,O
107322,11,did,O
107322,11,the,O
107322,11,eosinophilia,O
107322,11,(,O
107322,11,5.5,O
107322,11,%,O
107322,11,when,O
107322,11,last,O
107322,11,checked,O
107322,11,on,O
107322,11,[,O
107322,11,**8-17**,O
107322,11,],O
107322,11,),O
107322,11,.,O
107322,11,#,O
107322,11,Transaminitis,O
107322,11,:,O
107322,11,Patient,O
107322,11,had,O
107322,11,elevated,O
107322,11,LFTs,O
107322,11,at,O
107322,11,admission,O
107322,11,",",O
107322,11,statin,B-Drug
107322,11,was,O
107322,11,held,O
107322,11,.,O
107322,11,LFTs,O
107322,11,trended,O
107322,11,down,O
107322,11,",",O
107322,11,statin,B-Drug
107322,11,was,O
107322,11,restarted,O
107322,11,.,O
107322,11,LFTs,O
107322,11,inadvertently,O
107322,11,checked,O
107322,11,[,O
107322,11,**8-23**,O
107322,11,],O
107322,11,",",O
107322,11,mildly,O
107322,11,elevated,O
107322,11,again,O
107322,11,",",O
107322,11,statin,B-Drug
107322,11,held,O
107322,11,.,O
107322,11,Medications,O
107322,11,on,O
107322,11,Admission,O
107322,11,:,O
107322,11,1,O
107322,11,.,O
107322,11,Warfarin,B-Drug
107322,11,2.5,O
107322,11,mg,O
107322,11,daily,O
107322,11,2,O
107322,11,.,O
107322,11,Carvedilol,B-Drug
107322,11,12.5,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,twice,O
107322,11,daily,O
107322,11,3,O
107322,11,.,O
107322,11,Isosorbide,B-Drug
107322,11,Mononitrate,I-Drug
107322,11,30,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,Sustained,O
107322,11,Release,O
107322,11,daily,O
107322,11,4,O
107322,11,.,O
107322,11,Losartan,B-Drug
107322,11,100,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,daily,O
107322,11,5,O
107322,11,.,O
107322,11,Omeprazole,B-Drug
107322,11,20,O
107322,11,mg,O
107322,11,Capsule,O
107322,11,",",O
107322,11,Delayed,O
107322,11,Release,O
107322,11,(,O
107322,11,E.C,O
107322,11,.,O
107322,11,),O
107322,11,daily,O
107322,11,6,O
107322,11,.,O
107322,11,Nitroglycerin,B-Drug
107322,11,0.3,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,",",O
107322,11,Sublingual,O
107322,11,as,O
107322,11,needed,O
107322,11,for,O
107322,11,chest,B-Reason
107322,11,pain,I-Reason
107322,11,7,O
107322,11,.,O
107322,11,Simvastatin,B-Drug
107322,11,80,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,daily,O
107322,11,8,O
107322,11,.,O
107322,11,Lasix,B-Drug
107322,11,40,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,daily,O
107322,11,9,O
107322,11,.,O
107322,11,Potassium,B-Drug
107322,11,Chloride,I-Drug
107322,11,20,O
107322,11,mEq,O
107322,11,Tab,O
107322,11,Sust.Rel,O
107322,11,.,O
107322,11,daily,O
107322,11,as,O
107322,11,needed,O
107322,11,for,B-Reason
107322,11,hypokalemia,I-Reason
107322,11,10,O
107322,11,.,O
107322,11,Olanzapine,B-Drug
107322,11,2.5,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,",",O
107322,11,Rapid,O
107322,11,Dissolve,O
107322,11,twice,O
107322,11,daily,O
107322,11,11,O
107322,11,.,O
107322,11,Olanzapine,B-Drug
107322,11,2.5,O
107322,11,mg,O
107322,11,Tablet,O
107322,11,",",O
107322,11,Rapid,O
107322,11,Dissolve,O
107322,11,q6h,O
107322,11,PRN,O
107322,11,severe,B-Reason
107322,11,agitation,I-Reason
107322,11,.,O
107322,11,Discharge,O
107322,11,Medications,O
107322,11,:,O
107322,11,none,O
107322,11,Discharge,O
107322,11,Disposition,O
107322,11,:,O
107322,11,Extended,O
107322,11,Care,O
107322,11,Discharge,O
107322,11,Diagnosis,O
107322,11,:,O
107322,11,respiratory,O
107322,11,failure,O
107322,11,Discharge,O
107322,11,Condition,O
107322,11,:,O
107322,11,died,O
107322,11,Discharge,O
107322,11,Instructions,O
107322,11,:,O
107322,11,None,O
107322,11,Followup,O
107322,11,Instructions,O
107322,11,:,O
107322,11,None,O
107322,11,[,O
107322,11,**Initials,O
107322,11,(,O
107322,11,NamePattern4,O
107322,11,),O
107322,11,**,O
107322,11,],O
107322,11,[,O
107322,11,**Last,O
107322,11,Name,O
107322,11,(,O
107322,11,NamePattern4,O
107322,11,),O
107322,11,**,O
107322,11,],O
107322,11,[,O
107322,11,**Name8,O
107322,11,(,O
107322,12,MD,O
107322,12,),O
107322,12,**,O
107322,12,],O
107322,12,MD,O
107322,12,[,O
107322,12,**MD,O
107322,12,Number,O
107322,12,(,O
107322,12,1,O
107322,12,),O
107322,12,292**,O
107322,12,],O
